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INTRODUCTION
In vitro fertilization (IVF) has been developed since
more than 30 years back. Although the fertilization
rate has slowly reaching to 90%, the live birth rate
of this procedure has been constant with just a
slight improvement in these recent years. When
added with the pregnancy rate, it only occurs
around 35-42% in all IVF centers worldwide.1 In
Abstract
Objectives: To compare the oocyte count, embryo count, pregnancy
rate, and the presence of OHSS in patients undergoing In Vitro Fer-
tilization (IVF) with long and short protocols at Yasmin Clinic, Dr.
Cipto Mangunkusumo Hospital, Jakarta.
Methods: A cross sectional study was done at Yasmin Reproductive
Clinic, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Data
was collected from the medical records of 200 infertile women un-
dergoing IVF, 100 women with long protocols and the other 100
with short protocols. Variables compared in these 2 groups are the
oocyte count, embryo count, the pregnancy rate, and presence OHSS
using Mann-Whitney U Test with SPSS 11 Program.
Result: From 200 women undergoing IVF procedure, 45.5% of them
aged between 35-40 years old, with the youngest is 22 years old and
the oldest is 48 years old (average age=35 years, SD=4.7), and al-
most half of them (45%) have BMI between 18.01-23.00 kg/m2. 185
women has primary infertility. These subjects came to the clinic
mostly due to male factor (23.5%), idiopathic cause (19%), and ovu-
lation disturbance (13%), whilst endometriosis, tubal factor, and
other factors take just little percentage. When compared between
long and short protocols, the number of oocyte retrieved is signifi-
cantly different (p=0.007, CI=5.84-7.11), whereas embryo numbers
(p=0.054, CI=1.80-2.39) and the pregnancy rate (p=0.525, CI=0.21-
0.33) found to be not significantly different. There were 2 cases of
moderate OHSS developed in the long protocol group.
Conclusion: Although the number of embryo produced and the
pregnancy rate are found to be not significantly different between
the two groups, long protocol of IVF is found to produce more oocyte
to be retrieved and develop more OHSS events compared to short
protocol. Due to this result, GnRH antagonist can be considered
when planning an IVF procedure. However, a longitudinal multicen-
ter study with larger sample size is needed to validate the current
data.
[Indones J Obstet Gynecol 2012; 36-2: 95-9]
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Abstrak
Tujuan: Membandingkan jumlah oosit, embrio, angka keberhasilan
kehamilan, dan angka kejadian OHSS pada pasien yang mengikuti
program fertilisasi in vitro dengan protokol panjang dan protokol pen-
dek di Klinik Yasmin Rumah Sakit Dr. Cipto Mangunkusumo.
Metode: Penelitian ini menggunakan desain potong lintang dilakukan
di Klinik Yasmin, pusat layanan gangguan haid dan kesuburan, RS Dr.
Cipto Mangunkusumo, Jakarta. Data diambil dari dua ratus rekam
medis pasien perempuan infertil yang mengikuti program fertilisasi in
vitro (FIV) terbagi ke dalam kedua kelompok yaitu 100 pasien yang
menjalani protokol panjang dan 100 yang mengikuti protokol pendek.
Variabel yang dibandingkan dari kedua kelompok ini adalah jumlah
oosit, embrio, keberhasilan kehamilan, dan angka kejadian OHSS.
Hasil: Dari 200 perempuan yang mengikuti program FIV, 45,5% di
antaranya berusia 35-40 tahun, dengan usia termuda 22 tahun dan
tertua 48 tahun (rata-rata 35 tahun, SD=4,7), dan kebanyakan dari
mereka (45%) memiliki BMI di antara 18,01-23,00 kg/m2. 185 perem-
puan mengalami infertilitas primer. Subjek dalam penelitian ini ke-
banyakan mengalami infertilitas akibat faktor lelaki (23,5%), idiopa-
tik (19%) dan gangguan ovulasi (13%), sementara penyebab lain se-
perti endometriosis, faktor tuba, dan faktor lain ditemukan dalam
porsi yang lebih kecil. Saat membandingkan antara protokol panjang
dan protokol pendek, terdapat perbedaan yang bermakna pada jum-
lah oosit yang dipetik (p=0,007, CI=5,84-7,11). Tidak terdapat perbe-
daan yang bermakna pada jumlah embrio (p=0,054, CI=1,80-2,39)
dan laju kehamilan (p=0,525, CI=0,21-0,33). Terjadi 2 kasus OHSS
derajat sedang pada grup protokol panjang.
Kesimpulan: Walaupun saat membandingkan jumlah embrio dan
laju kehamilan pada kedua protokol tidak ditemukan perbedaan yang
bermakna, protokol panjang FIV diketahui menghasilkan lebih ba-
nyak oosit yang dipetik dan menimbulkan 2 kejadian OHSS diban-
dingkan dengan protokol pendek. Dari hasil ini, GnRH antagonis dapat
dipertimbangkan pada perencanaan prosedur IVF. Namun, studi long-
itudinal multi-senter dengan jumlah sampel yang lebih besar dibutuh-
kan untuk validasi data yang ada.
[Maj Obstet Ginekol Indones 2012; 36-2: 95-9]
Kata kunci: fertilisasi in vitro, kehamilan, protokol panjang, protokol
pendek
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Indonesia, its success rate has shown a similar
numbers, reaching 48.68% in women less than 35
years old and 7.94% in women older than 42 years
old.2
Women undergone IVF might have one or more
possible causes, such as ovulation problem, tubal
factor, idiopathic or other causes such as endome-
triosis and fibroids.3 A woman may not ovulate be-
cause the hypothalamus does not secrete gonado-
trophin-releasing hormone (GnRH), which is res-
ponsible for stimulating the pituitary gland to
produce the luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) that trigger ovulation.
GnRH stimulation to release FSH and LH will in-
duce the development of follicles. When there is an
ovulation problem in a woman, and she went to
seek a fertility treatment, often one of the two ty-
pes of GnRH analogues, GnRH-agonists and GnRH-
antagonists, is given together with other related
drugs, such as gonadotrophin recombinant and
hCG, to enhance stimulation for in vitro fertilization
(IVF) process or intra uterine insemination (IUI).
These GnRH analogues have an important role in
reducing the incidence of premature LH surges by
blocking pituitary secretion.4,5
GnRH agonist have been widely used as the
"gold standard" protocol in ovarian stimulation for
more than 20 years.6 GnRH antagonist that re-
cently introduced7 has offered several advantages,
including lower total dosages of gonadotrophins,
less incidence of hyperstimulation syndrome, lo-
wer cost, lack of side effects, shorter duration of
treatment and more individualized and less aggres-
sive protocol.8,9
These two GnRH analogues have different ways
in inducing ovulation. The GnRH-agonists used in
the long protocol, which started either in the mid
luteal phase or in the early follicular phase of the
preceding cycle, will cause an initial surge in both
FSH and LH production. But then it will cause the
body to cease production of these hormones, thus
preventing ovulation and limiting estrogen. Mean-
while GnRH-antagonists, used in short protocol,
will immediately suppressing the FSH and LH pro-
duction, thus suppressing ovulation.10
Several studies have directly compared these new
stimulation protocols against the long GnRH agonist
protocol in terms of number of oocytes collected,
number of embryos obtained, implantation rate, and
mainly focus on pregnancy rate and incidence of ova-
rian hyperstimulation syndrome (OHSS). Although
several data has previously describes that GnRH
antagonist have a lower pregnancy rate,10-13 an-
other data has shown that the live birth probability
between two groups was not significantly differ-
ent.14 The development of OHSS cases was re-
ported to be higher in the long protocol group com-
pared to the short one.12,15 Devroey and Andriaen-
sen (2011) also emphasize that in order to avoid
the presence of OHSS, clinician should do all stimu-
lations with GnRH antagonist.16
OBJECTIVES
Looking at the previously reported data, our cur-
rent study tried to compare several outcome vari-
ables of IVF between two protocols. The objective
of this study was to compare the oocyte count, em-
bryo count, the pregnancy rate, as well as the pres-
ence of OHSS in women undergone In Vitro Fertili-
zation (IVF) with long and short protocols at Yas-
min Clinic, Dr. Cipto Mangunkusumo Hospital, Ja-
karta. This first pilot project done in Indonesia is
aiming to look for the different outcome between
giving GnRH agonist and GnRH antagonist in such
patients.
METHODS
This present study used a cross sectional design of
a total 200 patients. The patients in the study were
women who attended Yasmin Reproductive Clinic,
Dr. Cipto Mangunkusumo Hospital, Jakarta, Indo-
nesia, and undergoing IVF in the period between
November 2009 and March 2011. Patients who
came between this period with uncompleted data
or cancelled procedure are not included in the
study. The data were collected from the medical
records, which then divided into 2 groups, 100
women with long protocols and the other 100 with
short protocols. No ethical approval was needed,
as it is a cross sectional analysis of already avail-
able data.
The long protocol controlled ovarian hypersti-
mulation used combination of gonadotrophin re-
leasing hormone (GnRH) agonist (Suprefact, Buse-
relin) and recombinant FSH (r-FSH) (Puregon, Go-
nal). The short protocol controlled ovarian hyper-
stimulation used combination of GnRH antagonist
(Cetrotide) and r-FSH (Puregon, Gonal). The admi-
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nistration of GnRH agonist, r-FSH, GnRH antago-
nist, hCG injection, gametes disposing, embryo cul-
ture, and embryo transfer were all undergone ac-
cording to our regular manipulation in Yasmin
Clinic. Fourteen days after pituitary desensitization
with GnRH agonist, there was evaluation of follicle
maturation by ultrasonography and by serum oes-
tradiol concentration. Then r-FSH was adminis-
tered at a dose of 150-450 IU according to the
ovarian reserve. The r-FSH dose was adjusted ac-
cording to the degree of ovarian response, evalu-
ated by ultrasound examination and by serum es-
tradiol concentration. The hCG administration
(5000 IU-10000 IU) was done if there was follicles
of > 18 mm in diameter, usually on day 12-14 of
rFSH administration. Oocytes were retrieved 32-36
hours after hCG administration under transvaginal
ultrasound guidance.
Embryos were transferred 2 or 3 days later after
oocyte retrieval. The embryos were evaluated by
embryologist on the day of fertilization, day of
cleavage I, and day of cleavage II. The evaluation
included the blastomeres and fragmentation. Em-
bryos with ≥ 4 cells on cleavage I and embryos with
≥ 8 cells on cleavage II were calculated. All embryos
calculated had < 20% fragmentation of the total
embryonic volume. 
A serum ß-hCG test was done to confirm preg-
nancy two weeks after embryo transfer. Clinical
pregnancy was diagnosed 3 weeks after a positive
test by the presence of a gestational sac with fetal
echoes and pulsations on ultrasound.
Data were presented as mean ± SD. Different
variables compared in these 2 groups were the oo-
cyte count, embryo count, the pregnancy rate, and
the presence of OHSS with the analysis using
Mann-Whitney U Test from SPSS 11 Program. P
values < 0.05 were considered to be significant.
Statistics were done using SPSS version 11.
RESULT
This study include a total of 200 women, whose
age ranging between 22-48 years old (mean 35.6
±4.6) and BMI between 19.55-35.49 kg/m2 (mean
23.03±3.4), who are divided into two groups: group
I (long protocol) included 100 subjects, while
group II (short protocol) included 100 subjects.
There was no statistically significant difference be-
tween the two groups regarding their age and BMI
level. With 45.5% of them aged between 35-40
years old and most of them (45%) have BMI be-
tween 18.01-23.00 kg/m2, 185 women has primary
infertility.
These subjects came to the clinic mostly due to
male factor (23.5%), idiopathic cause (19%), and
ovulation disturbance (13%), whilst endometrio-
sis, tubal factor, and other factors take just little
percentage (Table 2).
Table 2. Causes of Patient’s Infertility.
Overall Long
Protocol
Short
Protocol
Idiopathic 38 (19%)  25  13  
Endometriosis 20 (10%)  6 14  
Ovulation Disturbance 26 (13%)  7 19  
Male Factor 47 (23.5%) 25  22  
Tubal Factor 18   (9%)    11  7
Male and Female Factors 29 (14.5%) 14  15  
Others 22 (11%)  12  10  
The antral follicle count (AFC) and basal hormo-
nal level characteristics of the patients recruited in
this study varies as shown in Table 3.
Table 1. Data distribution based on patient’s age and BMI.
Age BMI
< 35 35-40 > 40 < 18.0 18.01-23.00 23.01-25.00 > 25.01
Overall 89 (44.5%) 91 (45.5%) 20 (10%) 11 (5.5%) 90 (45%) 54 (27%) 45 (22.5%)
Long Protocol 47 46  7 8 43 29 20
Short Protocol 42 45 13 3 47 25 25
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Table 3. Basal Level Characteristics.
Basal Level Minimum Maximum Mean
FSH 1.2 39 7.78±4.57
E2 8 505.27 52.41±51.04
LH 0.1 39 5.48±5.27
Anti-Müllerian
Hormone (AMH)
0.1 13.7 3.08±3.21
Antral Follicle
Count (AFC)
0 20 7±3.65
Regarding all women, clinical pregnancy was
achieved in 54 women (27%) and miscarriage rate
was 12.9% mainly in the first eight weeks. There
are 4 cases of twin and 1 triplets in long protocol
whereas 5 twin cases in the short protocol group.
Table 4. Outcome measures in both groups.
Variable Long Protocol
Short
 Protocol
p
 Value CI
Oocyte Count 7.22±4.60 5.73±4.41 0.007 5.84-7.11
Embryo Count 2.26±1.95 1.93±2.26 0.054 1.80-2.39
Clinical Pregnancy
Rate
29% 25% 0.525 0.21-0.33
OHSS 2 0 0.156 -0.04-0.08
As presented in Table 4, when the variables are
compared between long and short protocols, the
number of oocyte retrieved is significantly differ-
ent, whereas embryo numbers and the pregnancy
rate found to be not significantly different. Two
cases of OHSS were developed in the long protocol
group.
DISCUSSION
The result of current study is consistent with pre-
vious studies mentioning that there is no signifi-
cant different of the pregnancy outcome from both
groups. Despite looking at the significant higher
number of oocytes retrieved in the long protocol
group, a direct conclusion about the superiority of
long protocol cannot be taken since the embryo
count and the pregnancy rate has no significant dif-
ference between these two groups. Due to this, the
use of short protocol should be taken into consi-
deration. Even though the finding of moderate OH-
SS development is not significantly different bet-
ween the two groups, the fact that OHSS only de-
veloped in the long protocol group should be taken
into consideration when choosing the treatment
for such patients, and it was consistent with pre-
vious studies reporting the same result. To add to
the statement, many previous studies has also dis-
cussed and reported that the use of short protocol
can reduce the presence of mild, moderate, and
mostly, severe OHSS cases.
Our current study is a pilot project involving
only 1 IVF center in Jakarta, Indonesia, and it is the
first study to compare the outcome of IVF between
long and short protocols. A limitation of this study
is that the patient’s age range is too wide, whilst if
the data narrowed down into just a group of age
(e.g. more than 40 years old), the number of data
will be small. This should be taken into considera-
tion when doing a further study. As discussed pre-
viously, because the subjects are taken from only
1 center, the data cannot be used as general infor-
mation. A further study from multiple IVF centers
is needed to validate the data provided. Further-
more, adding more variables to be compared, such
as the live birth rate, will also make the data more
comprehensive.
CONCLUSION
Although the number of embryo produced and the
pregnancy rate is found to be not significantly dif-
ferent between the two groups, long protocol of
IVF found to produce more oocyte retrieved com-
pared to short protocol. Long protocol also pro-
duced 2 OHSS event, thus clinician should be more
careful in using this protocol for their patients. This
data provides a suggestion of using GnRH antago-
nist or short protocol for IVF because of their bene-
fits. However, a longitudinal multicenter study with
larger sample size is needed to validate the current
data.
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